Stay updated on IMMU-132 Clinical Trial in Epithelial Cancer
Sign up to get notified when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.

Latest updates to the IMMU-132 Clinical Trial in Epithelial Cancer page
- Check7 days agoChange DetectedThe page metadata/footer now includes a glossary toggle, a 'Last Update Submitted that Met QC Criteria' label, a 'No FEAR Act Data' label, and a new 'Revision: v3.4.0' tag, while the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible edits to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedDifference0.9%

- Check71 days agoChange DetectedAdditions clarify publication provenance: voluntariness of submissions, PubMed auto-fill, and a Revision: v3.3.2 tag. Deletions remove older phrasing that publications are automatically created by ClinicalTrials.gov using the NCT number and may be about the study results.SummaryDifference0.1%

- Check78 days agoChange DetectedRemoval of the funding-status notice about potential delays due to government funding; this did not affect the study data or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check93 days agoChange DetectedMinor layout/formatting updates to the Study Details page; no changes to core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to IMMU-132 Clinical Trial in Epithelial Cancer
Enter your email address, and we'll notify you when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.